Lanthanide‐based susceptibility contrast agents: Assessment of the magnetic properties
- 1 February 1996
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 35 (2) , 201-206
- https://doi.org/10.1002/mrm.1910350211
Abstract
The T2* contrast efficacy of paramagnetic contrast agents is dependent on their magnetic properties. Vibrating sample magnetometry (VSM) and the Live Chan NMR method have been used to evaluate the influence of ligand structure on the bulk magnetic susceptibility (BMS) of low-molecular weight (LMW) lanthanide chelates. VSM was also used for the BMS assessment of LMW lanthanide chelates covalentiy attached to cross-linked starch particles. The ligand structure had no influence on the BMS of the gadolinium (Gd) and dysprosium (Dy) chelates. The mean BMS value of the Dychelates was 1.8 fold higher than that of the Gd-chelates. The holmium (Ho) OTPA-BMA chelate had a similar BMS to that of Dy-DTPA-BMA while the lowest BMS was found for europium (Eu(lll)) DTPA-BMA. The covatent attachment of Gd-DTPA and Dy-DTPA to a cross-linked starch particle had no impact on their intrinsic magnetic properties. The BMS data were in good accordance with those obtained for non-particulate bound LMW Dy- and Gd-chelates. The magnetic susceptibility of the Gd-OTPA labeled particles was described by the Curie law, indicative of no magnetic interactions between Gd-DTPA molecules. The magnetic susceptibility of the Dy-DTPA labeled particles followed the Curie-Weiss law with a Curie-Weiss temperature of about -2 K, indicating magnetic interactions. The magnetic susceptibility of Dy-DTPA will, however, not be affected by such magnetic interactions at physiological temperatures.Keywords
This publication has 17 references indexed in Scilit:
- Microscopic susceptibility variation and transverse relaxation: Theory and experimentMagnetic Resonance in Medicine, 1994
- Contrast agents for cerebral perfusion MR imagingJournal of Magnetic Resonance Imaging, 1994
- Intravascular susceptibility contrast mechanisms in tissuesMagnetic Resonance in Medicine, 1994
- Reperfused myocardial infarctions on T1‐ and susceptibility‐enhanced MRI: Evidence for loss of compartmentalization of contrast mediaMagnetic Resonance in Medicine, 1994
- Susceptibility changes following bolus injectionsMagnetic Resonance in Medicine, 1993
- Chelates of gadolinium and dysprosium as contrast agents for MR imagingJournal of Magnetic Resonance Imaging, 1993
- Contrast media for cardiothoracic MR imagingJournal of Magnetic Resonance Imaging, 1993
- Magnetic susceptibility shift selected imaging: MESSIMagnetic Resonance in Medicine, 1990
- Perfusion imaging with NMR contrast agentsMagnetic Resonance in Medicine, 1990
- Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effectsMagnetic Resonance in Medicine, 1988